← Open Payments lookup

RYAN CHO: Open Payments

NPI 1477070670 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,133 in 60 payments from 8 companies in 2025. Trend: 2023 $43 · 2024 $373 · 2025 $1,133

Food & beverage: $1,133
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.13$414
AstraZeneca Pharmaceuticals LP6$211
Salix Pharmaceuticals, a division of Bausch Health US, LLC18$172
Exact Sciences Corporation14$159
Lilly USA, LLC3$71
Novo Nordisk Inc3$56
Amgen Inc.2$34
Astellas Pharma US Inc1$15

Products named: Kerendia, XIFAXAN, Cologuard Collection Kit, FARXIGA, AIRSUPRA, Ozempic, MOUNJARO, OTEZLA.

Industry payments across NV — which companies pay providers there.